Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis

Emerging Infectious Diseases
Marian LovedayJennifer Furin

Abstract

Little is known about the treatment experiences of pregnant women with rifampin-resistant tuberculosis. We conducted qualitative interviews with 10 women who had this condition; 9 reported facing discrimination from healthcare providers. Our findings underscore an urgent need to ensure a human-rights-based, patient-centered approach for women with rifampin-resistant tuberculosis who are pregnant.

References

Apr 14, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eda PalaciosSonya Shin
Mar 15, 2011·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·P TabarsiA Velayati
Sep 4, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jyoti S Mathad, Amita Gupta
Sep 6, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A S DharmadhikariE Nardell
Dec 1, 2014·The Lancet Global Health·Alimuddin ZumlaPeter Mwaba

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.